Research Article

Comparison of General and Liver-Specific Prognostic Scores in Their Ability to Predict Mortality in Cirrhotic Patients Admitted to the Intensive Care Unit

Table 1

Demographics, clinical features, and outcomes of cirrhotic patients admitted to the ICU.

CharacteristicsAll patients (n = 382)Patients with ACLF (n = 178)Cirrhosis with AD (n = 204)

Age (years)67.3 ± 10.658.2 ± 24.762.4 ± 20.8
Male sex280 (73%)133 (74.7%)147 (72.1%)
Ascites321 (84%)154 (86.5%)167 (81%)
Hepatic encephalopathy211 (55%)110 (61.7%)101 (49.5%)
Variceal bleeding24 (6%)12 (6.7%)12 (5.9%)
Bacterial infections/sepsis233 (61%)98 (55%)135 (66%)
Acute kidney injury123 (32%)80 (45%)43 (21%)
ACLF by CLIF-C criteria178 (47%)
(i) Grade I90 (24%)
(ii) Grade II36 (9%)
(iii) Grade III52 (14%)
ACLF by NACSELD criteria33 (9%)
Serum sodium (mEq/L)1136 (132–140) 109–157137 (131–140) 109–157136 (132–140) 109–155
Serum creatinine (g/dl)11.0 (0.7–1.6) 0.3–8.41.4 (0.87–2.5) 0.4–8.40.9 (0.6–1.2) 0.3–3.5
Serum albumin (mg/dl)12.5 (2.2–2.9) 0.4–4.42.5 (2.1–2.9) 1.0–4.22.6 (2.3–2.9) 0.4–4.4
Serum bilirubin (mg/dl)12.0 (1.2–4.2) 0.4–36.72.3 (1.2–5.3) 0.4–36.72.0 (1.1–3.10) 0.4–27
INR11.7 (1.4–2.1) 0.51–13.441.87 (1.4–2.3)0.93–12.71.6 (1.4–2.0) 0.5–3.4
Leukocyte count (109/L)17,330 (5,060–11,030) 1,070–45,0908,670 (6,460–13,722) 1,070–45,0906,545 (4,360–6,545) 1,140–24,120
MELD-Na22 ± 8
SOFA4 ± 3
CLIF-SOFA5 ± 3
CLIF-C OF8 ± 2
CLIF-C ACLF48 + 12
CLIF-C AD57 + 9
ICU length of stay14.0 (2.0–9.0) 0.8–51.05 (2–10) 1.0–51.03.0 (1–6) 1.0–29.0
Hospital length of stay111.0 (8.0–18.0) 1.0–103.016.5 (9.0–12.5) 1.0–103.010 (7–16) 1.0–64.0
Mortality118 (30.9%)95 (53.4%)23 (11.3%)

1Expressed by median (25th–75th)/min–max; ACLF, acute-on-chronic liver failure; CLIF-C, Chronic Liver Failure Consortium; NACSELD, North American Consortium for the Study of End-Stage Liver Disease; MELD, Model for End-Stage Liver Disease; SOFA, Sequential Organ Failure Assessment; OF, organ failure; AD, acute decompensation; ICU, intensive care unit.